ACETAMINOPHEN; HYDROCODONE BITARTRATE | A201013 | AUROLIFE PHARMA LLC
Highest NADAC/Unit
$0.1522
per ea
Lowest NADAC/Unit
$0.1382
per ea
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 13107002105HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET | $0.1522 | EA | Generic | — | 2026-08-19 |
| 13107002199HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET | $0.1522 | EA | Generic | — | 2026-08-19 |
| 13107002101HYDROCODONE-ACETAMINOPHEN 10-325 MG TABLET | $0.1522 | EA | Generic | — | 2026-08-19 |
| 13107001905HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET | $0.1384 | EA | Generic | — | 2026-08-19 |
| 13107001901HYDROCODONE-ACETAMINOPHEN 5-325 MG TABLET | $0.1384 | EA | Generic | — | 2026-08-19 |
| 13107002005HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET | $0.1382 | EA | Generic | — | 2026-08-19 |
| 13107002001HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET | $0.1382 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.